PATENT CLAIM ANALYSIS

Application Number: 15764918
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "133100"]

Abstract:
The present invention provides antagonists of IL-17C for use in the treatment and/or prevention of atopic dermatitis and related conditions.

Claim (Index 17):
The method of  claim 13  wherein the treatment results in an improvement in an atopic dermatitis-associated parameter selected from the group consisting of:\n (a) a decrease from baseline in Investigator's Global Assessment (IGA) score of at least 40%; \n (b) a decrease from baseline in Body Surface Area Involvement of Atopic Dermatitis (BSA) score of at least 40%; \n (c) a decrease from baseline in Eczema Area and Severity Index (EASI) score of at least 55%; \n (d) a decrease from baseline in SCORAD score of at least 40%; and \n (e) a decrease from baseline in 5-D Pruritus Scale of at least 25%; and (f) a decrease from baseline in Pruritus Numeric Rating Scale (NRS) score of at least 45%.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.05
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15711815', '14632988', '14328336', '15436032', '15563743']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7610640708859316
- 35 USC 102 Novelty (BERT): 0.517131183485915
- Combined Prediction Score: 0.73667078214593
- Mean Citation Score: 293.713394
- Max Citation Score: 319.89307
- Similarity Product: 241.3725258244956

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test